(Natural News)—In a groundbreaking report released this week, a Florida grand jury has uncovered “profound and serious issues” in the U.S. vaccine development and safety surveillance system. While the jury found no criminal activity, it revealed a troubling pattern of “deceptive and obfuscatory behavior” by pharmaceutical companies and regulators, raising urgent questions about transparency, ethics, and accountability in the nation’s public health infrastructure.
The grand jury, convened by Florida Governor Ron DeSantis in December 2022, was tasked with investigating “any and all wrongdoing” related to COVID-19 vaccines. After a year-long review of documents, interviews with key witnesses, and an examination of the vaccine production process, the jury’s 140-page report paints a damning picture of a system rife with conflicts of interest, lack of transparency, and ethical lapses.
“While we did not find criminal activity,” the report states, “we did find a pattern of deceptive and obfuscatory behavior on the part of sponsors and regulators that often straddled the line between ethical and unethical conduct.” The report emphasizes that the absence of criminal charges does not equate to an absence of problems. On the contrary, it highlights systemic flaws that, if left unaddressed, will continue to undermine public trust in vaccines and the institutions tasked with safeguarding public health.
A system in need of reform
The grand jury’s findings reveal a litany of issues plaguing the vaccine development and regulatory process. Among the most alarming revelations is the failure of pharmaceutical giant Pfizer to disclose adverse events in pregnant women during one of its key clinical trials. These events were omitted from published studies in the New England Journal of Medicine and only came to light because Pfizer was legally required to post trial results on ClinicalTrials.gov.
The report also criticizes the FDA for its lax enforcement of marketing restrictions on vaccine companies. For example, Moderna’s 2021 ad campaign, which featured a former athlete urging Americans to “protect the team” by getting vaccinated, was allowed to run despite promoting vaccination in general rather than a specific product. This blurring of lines between public health messaging and corporate advertising raises concerns about the FDA’s role as a regulator versus a cheerleader for the pharmaceutical industry.
Perhaps most troubling is the “revolving door” between the FDA and the pharmaceutical industry, a phenomenon documented in a 2024 investigation by Peter Doshi, Ph.D., senior editor at The BMJ. Doshi’s research revealed that departing FDA staff often take lucrative positions in the pharmaceutical sector, where they continue to influence regulatory decisions “behind the scenes.” This cozy relationship, the grand jury argues, undermines the FDA’s ability to act as an impartial watchdog.
Recommendations for change
The grand jury’s report is not merely a critique; it is a call to action. The jury offers six key recommendations to reform the vaccine development and regulatory process:
- Address the revolving door: The public must confront the pervasive conflicts of interest created by the movement of personnel between government agencies and the pharmaceutical industry.
- Disclose safety signals immediately: Vaccine makers should be required to publicly disclose safety signals as soon as they are identified, rather than waiting for confirmation. The report argues that treating the public as incapable of understanding nuanced information is “infantilizing and paternalistic.”
- Conduct updated clinical trials: Pfizer and Moderna’s COVID-19 vaccines should undergo updated clinical trials to address lingering questions about their safety and efficacy.
- Ban direct-to-consumer marketing: The practice of pharmaceutical companies advertising directly to consumers should be prohibited to prevent the manipulation of public perception.
- Publish anonymized patient data: Vaccine makers must swiftly release anonymized individual patient data from safety and efficacy studies after receiving FDA licensure.
- Remove legal immunity: Companies that fail to comply with data transparency requirements should lose their legal immunity from lawsuits.
A call for systemic change
The grand jury’s report is careful to avoid taking sides in the polarized debate over COVID-19 vaccines. It acknowledges that the vaccines have been hailed as a “triumph of science” by some and criticized as recklessly overpromoted by others. Both perspectives, the report suggests, contain elements of truth.
What the jury seeks is not to fuel ideological battles but to spark a much-needed conversation about systemic reform. “If this Final Report accomplishes nothing else,” the authors write, “we are optimistic that it can elevate the debate around the many nuanced and specific issues involving these pharmaceuticals by clearly describing and contextualizing them.”
Governor DeSantis echoed this sentiment in a statement on X, emphasizing that the status quo is untenable. “The American people deserve transparency on how Big Pharma is using their federal tax dollars,” he said, “and they deserve regulating entities that operate as watchdogs, not cheerleaders.”
A blueprint for the future
The grand jury’s findings and recommendations represent a critical step toward restoring public trust in the vaccine development process. By shining a light on the ethical and systemic issues that have plagued the system, the report provides a blueprint for meaningful reform.
As the nation grapples with the lessons of the COVID-19 pandemic, this report serves as a stark reminder that transparency, accountability, and ethical governance are not optional—they are essential to the health and well-being of the American people. The question now is whether policymakers, regulators, and the pharmaceutical industry will heed this call for change or continue to prioritize profit over public trust.
For those who value natural health and informed consent, the grand jury’s report is a vindication of long-held concerns about the influence of Big Pharma and the need for a more balanced, transparent approach to public health. The time for systemic change is now.
Sources include:
Two Storms, One Harvest
Every food crisis in living memory has been a one-shock event. The 2008 price spike was a commodity bubble. The 2020 shortages were a logistics failure. The 2022 grain scare was a war on one exporter’s ports. Each time, the system bent, adjusted, and recovered, and each time the experts assured us afterward that global markets are simply too big and too diversified to fail.
What nobody in Washington seems eager to discuss is that 2026 is shaping up to be something the modern food system has never actually faced. Two independent shocks, one climatic and one geopolitical, are converging on the same harvest cycle at the same time. Not sequentially. Simultaneously.
Start with the weather. The Pacific Ocean is currently building toward what forecasters now openly call a record event. NOAA’s Climate Prediction Center puts the odds of at least a strong El Niño near 88 percent, with roughly two in three odds it reaches “very strong” status, the tier reserved for perhaps three or four events in the entire satellite era. Every major global model now projects a median peak in Super El Niño territory, and most of them project it exceeding the 2015-16 event, which until now held the modern record. Sea surface anomalies were already brushing the super threshold in mid-July, months before these events normally peak. The atmosphere has already shifted into El Niño mode, and the event is forecast to crest in late fall and early winter.
This is not about “climate change.” It’s about the standard cycles of weather, and the cycle we’re currently in is one that has likely devastated societies in the past. We’re better prepared as a society today, but not all Americans are equally prepared.
Serious households have started doing the quiet math on their own. Grocery bills tell part of the story, and the forecast maps tell the rest, which is why long-term food storage has moved from fringe hobby to mainstream line item in the family budget, with established suppliers like Heaven’s Harvest seeing demand from people who five years ago would have rolled their eyes at the idea. That instinct is not paranoia. It is pattern recognition, and the pattern is worth walking through carefully.
Editor’s Note: Heaven’s Harvest IS a sponsor, but the warnings of this article are real and would be written even if we didn’t have a survival food sponsor. With that said, those who take advantage of what they offer can use promo code “Patriot” for 15% off.
The Fertilizer Clock Is Already Running
While the Pacific warms, the second shock has been unfolding in the Strait of Hormuz. The conflict with Iran turned the world’s most important energy chokepoint into a contested waterway, and the consequences reach far beyond the gas pump. Roughly a third of global fertilizer trade moves through Hormuz, and the disruption sent urea prices up 86 percent year over year by March, with a 53 percent jump in a single month.
The World Bank projects energy prices rising about 24 percent in 2026 and fertilizer about 31 percent. By its own accounting, fertilizer prices ran 35 percent higher in the first five months of this year than the same period last year.
Here is the mechanism the nightly news will not explain. Fertilizer is not a grocery item. It is a time-delayed input. The nitrogen a farmer in Iowa or Punjab could not afford to apply this spring does not show up as a problem this spring. It shows up as a thinner harvest six to twelve months later.
The World Bank’s own food security brief concedes that the effects of reduced applications earlier this season “are likely to become visible only later in harvest outcomes.” Translate that from institutional language into plain English and it means this. The damage is already done, it is already in the ground, and we are simply waiting for it to arrive on the shelf.
Now check the calendar. Six to twelve months from the spring planting season lands us squarely in late 2026 and early 2027. Which is precisely when the strongest El Niño in the instrumental record is forecast to peak, bringing its signature droughts to Southeast Asia, Australia, southern Africa, northern Brazil, and South Asia, the very regions that grow the world’s rice, sugar, and oilseeds.
The World Bank warns openly that a strong El Niño “could disrupt multiple crop belts simultaneously” on top of the conflict-driven input costs. Their baseline projection assumes the Middle East disruptions ease by autumn. What in the last two years of Middle East history suggests that assumption is safe?
The System Has No Slack Left
The comfortable answer is that global markets always adjust. But adjustment requires slack, and the slack is gone. Global cereal production is expected to decline from last year’s records even before El Niño does its work. The UN World Food Programme, hardly a den of right-wing preppers, is calling this the most significant disruption to its supply chains since Covid and the invasion of Ukraine, and its supply chain director put the stakes bluntly.
Today’s supply chain challenges are tomorrow’s hunger crisis.
There is also a political dimension that markets cannot price. When food gets scarce, governments do not behave like economists. They behave like politicians. Export bans, hoarding mandates, and panic buying at the national level turned the modest rice shortfall of 2008 into a global crisis, and analysts are already warning that import-dependent nations are the first dominoes.
The 2015-16 Super El Niño, a far weaker event than what is now forecast, threw tens of millions into food stress across Africa and Asia. This one is projected to be stronger, and it arrives with fertilizer already rationed by price and shipping lanes already contested by missiles.
What Joseph Knew
Scripture does not treat preparation for lean years as faithlessness. It treats it as wisdom delivered in advance to those willing to act on it.
Behold, there come seven years of great plenty throughout all the land of Egypt: And there shall arise after them seven years of famine; and all the plenty shall be forgotten in the land of Egypt.
Joseph did not respond to that warning with a hashtag or a committee. He stored grain during the years of abundance, and when the famine came, Egypt stood while its neighbors begged. The lesson is not that famine is certain. It is that the time to prepare is precisely when preparation still looks optional.
Nobody who filled a pantry in a year of plenty has ever regretted it, and nobody standing in an empty aisle has ever been glad he waited for certainty.
None of this calls for panic, and panic is the enemy of sound judgment anyway. It calls for the same unglamorous prudence our grandparents considered ordinary. Keep some cash margin, know your local growers, and put real food in deep storage while it is cheap and available, because the entire arc of this story is that cheap and available is a closing window.
Families looking for a straightforward place to start can visit Heaven’s Harvest and use promo code Patriot for 15 percent off long-term storable food. The forecasts may yet soften, the strait may yet reopen, and we should pray they do. But hope is a fine thing to hold and a foolish thing to eat.
